Miscellaneous Dermatological Disorders

AMA Adopts Ethical Guidance on Medical Tourism

June 27, 2018

Medical tourism can raise issues of safety and quality, particularly for care that is unapproved or legally or ethically prohibited in the United States.

Birch Pollen-Related Foods Can Trigger Dermatitis Reactions

April 23, 2018

Of those with allergic reactions, 32 patients exhibited significant deterioration of AD. Compared to nonresponders, responders showed significantly higher specific immunoglobulin E (IgE) levels to birch pollen and apple in addition to a higher prevalence of allergic rhinoconjunctivitis.

Eskata Approved for Raised Seborrheic Keratoses

By December 15, 2017

The FDA approval was supported by two Phase 3 studies that demonstrated the safety and efficacy of Eskata for the treatment of raised seborrheic keratoses.

Crisaborole Safe for Long-Term Treatment of Atopic Dermatitis

October 11, 2017

Researchers assessed the long-term safety results from a multicenter, open-label, 48-week safety study of 517 patients ≥2 years of age with mild to moderate AD who continued crisaborole treatment after completing a 28-day phase 3 pivotal study.

Low-Dose Naltrexone Effective for Severe Genetic Blistering Disease

By August 03, 2017

Current treatments for Hailey-Hailey disease, a severe genetic blistering disease of intertriginous skin, have led to varied clinical outcomes with potentially severe side effects.

Topical System Tx Suggests Improved Healing Post-Laser Resurfacing

April 13, 2017

The researchers found that blinded investigator-rated healing was better for the tripeptide/hexapeptide system, with the difference reaching statistical significance at day 7.

Botox Injection Efficacy Examined in Overactive Bladder

April 10, 2017

The researchers found that for treatment of overactive bladder, the safety and efficacy of intradetrusor injection of onabotulinumtoxin A is sensitive to injection volume and depth.

Alopecia, BPH Treatments Linked to PED

By March 09, 2017

Among those who developed PED, the condition continued for months or years, despite patients stopping treatment.

Antifungal and Retinoid Combo Displays Anti-Aging Benefits

January 26, 2017

Climbazole enhances retinoid-associated biological activities in vivo and in vitro, according to a study published online January 19 in the International Journal of Cosmetic Science.

FDA-Approved Filler Juvèderm Volbella XC Now Available

By October 18, 2016

Allergan has announced the availability of Juvèderm Volbella XC for lip augmentation and for correction of perioral rhytids in adults over the age of 21.

FDA Grants TXA127 Orphan Drug Status for Rare Genetic Skin Disorder

By September 07, 2016

The Food and Drug Administration has granted Orphan Drug designation to TXA127 (Tarix Orphan) for the potential treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB), a rare genetic skin disorder.

Doxycycline Evaluated in Patients with Potentially Life-Threatening Form of Chronic Urticaria

July 11, 2016

Critical temperature thresholds do not predict which patients benefit from treatment

Sleep Loss Correlates With Disease Severity, QoL in Pediatric Dermatitis

April 13, 2016

For children with atopic dermatitis, clinical scores for sleep loss, pruritus, disease severity, and quality of life correlate well.

Significant Neck Laxity Improvements After High-Intensity Focused Radiofrequency

March 16, 2016

Fractional high-intensity focused radiofrequency (HiFR) delivered to the dermis is effective for skin laxity of the lower face/neck, according to a study published in Lasers in Surgery and Medicine.

Antifungal Skin Treatment Gets First Generic Approval

By March 14, 2016

The first generic for Oxistat Cream (oxiconazole nitrate) 1% has been approved by the FDA.

Rates of Revision for Septorhinoplasty Surgery Examined

March 11, 2016

The rate of revision septorhinoplasty is 3.3%, and specific patient characteristics correlate with increased revision rates, according to research published online in JAMA Facial Plastic Surgery.